Skip to main content
. 2022 Feb;33(2):342–356. doi: 10.1681/ASN.2021040439

Figure 8.

Figure 8.

Proposed mechanism mediating the protective action of renalase against cisplatin-induced CKD. RNLS agonist RP81-MNP improved renal functions in cisplatin-induced CKD, possibly through inhibiting the regulated necrosis and the inflammatory response to cisplatin.